Neurology News Alerts
- Alert FDA OKs Vagus Nerve Stimulator to Prevent Cluster Headaches
- Alert FDA OKs First Treatment for Lambert-Eaton Myasthenic Syndrome
- Alert Unpleasant Surprises With Blood Pressure Drug for PTSD
- Alert Neuronavigation System Recalled Due to Brain Damage Risk
- Alert Teva Recalls All Amlodipine/Valsartan Combination Products in US
- Alert FDA Warns of High Levels of Heavy Metals in Kratom
- Alert Mylan Recalls 15 Lots of Valsartan Products in US
- Alert FDA Warns Sellers of Illegal Tianeptine Supplements
- Alert FDA Warns of MS Worsening After Stopping Fingolimod (Gilenya)
- Alert ER Doctor, Pharmacist Among Dead in Chicago Hospital Shooting
- Alert FDA Grants Oleic Acid Qualified Heart Health Claim
- Alert FDA OKs Gamifant, First Drug for Rare Immune Disease HLH
- Alert Another Tainted 'Sartan' Recalled for Impurity
- Alert EMA Panel Backs First Oral-Only Drug for Deadly Disease
- Alert FDA Warns Against Using Unapproved Meds in Implanted Pain Pumps
- Alert FDA Goes Ahead With Approval of Sufentanil Despite Controversy
- Alert FDA Clears Clobazam Oral Film (Sympazan) for Lennox-Gastaut
- Alert FDA Panel Fails to Support Novel Opioid for Depression
- Alert Medicare Plans to Phase in Changes for Office-Visit Payments
- Alert Common Household Chemicals Tied to Language Delays in Kids